• News
  • Film and TV
  • Music
  • Tech
  • Features
  • Celebrity
  • Politics
  • Weird
  • Community
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
'Ozempic economy' explained as research suggests drug could save US taxpayers $173,000,000,000 a year

Home> News> Health

Published 20:59 3 Jul 2025 GMT+1

'Ozempic economy' explained as research suggests drug could save US taxpayers $173,000,000,000 a year

The diabetes drug could help to reform the US economy

Britt Jones

Britt Jones

Featured Image Credit: Getty Images/Steve Christo - Corbis

Topics: Ozempic, Health, Money, US News

Britt Jones
Britt Jones

Advert

Advert

Advert

Drugs like Ozempic have been hailed as a saver of money for US taxpayers, and the reason may surprise you.

Ozempic has been the subject of media attention over the last few years after range of celebrities - including the likes of Oprah Winfrey and Amanda Bynes - and opened up about using the drug for weight-loss purposes.

The weekly injection helps to lower blood sugar levels in the body by assisting helping to produce more insulin.

Since celebs began to open up about just how it helped them to manage their weight, regular people began to use it in droves.

Advert

Ozempic was approved in the US back in 2017 for use in adults with Type-2 diabetes, and while it isn't approved for weight loss, it doesn’t stop people from using it for that purpose anyway.

Fellow jabs Wegovy and Mounjaro, on the other hand, are both approved for weight-loss.

Anyway, now that the craze has died down (apparently), there has been some surprising results which have come from the popular drug and now it’s saving taxpayers’ money and businesses alike.

Ozempic could help the economy (Getty Stock)
Ozempic could help the economy (Getty Stock)

Advert

According to the Queen’s Business Review, it’s now an economic anchor.

This is because it helps people to lose weight... stay with me here.

While the review notes that people have gained back the weight they initially shed after they stopped using the drug, the weight loss Ozempic promotes is what could be a great thing for the economy, and business.

It shared the views of Professor Joseph Trunzo at the Bryant’s School of Health and Behavioral Sciences that: "There are many things that lead to people's behaviours around eating, and there’s no one treatment that will address all that."

Advert

Obviously, Ozempic isn’t a cure, but it does help a lot of people to change the way that they view eating and their habits.

So, how does it save money?

According to the outlet, ‘the financial cost of treating obesity is high, especially when accounting for the illnesses it can cause such as hypertension, type 2 diabetes, heart disease, and cancer’.

It is now dubbed the 'Ozempic economy' (Getty Stock)
It is now dubbed the 'Ozempic economy' (Getty Stock)

Advert

Annual medical costs for these things to the healthcare system is over $173 billion, as per federal calculations.

It also shared that employee productivity is also an indirect cost of obesity as the disease might lead to employees needing to take time off work, or losing productivity.

It claimed that this would make workplaces less financially productive due to obesity thanks to high costs of disability benefit payments and training costs for those who have physical constraints.

Global Data revealed that the New York state economy data shows that obesity costs $37.3 billion in reduced economic activity and has also led to 165,000 less employees in the workforce because they may not be able to work in some workplace conditions.

Advert

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for large-scale economic growth and increase the United States Gross Domestic Product (GDP) by 0.4 per cent.

UNILAD has contacted Novo Nordisk for comment.

Choose your content:

6 hours ago
9 hours ago
10 hours ago
11 hours ago
  • 6 hours ago

    Amazon Prime series with near-perfect RT score is labeled 'one of the best' by Stephen King

    The series starring Titus Welliver has been branded 'one of the most underrated TV shows'

    Film & TV
  • 9 hours ago

    People horrified after hearing tech billionaire Peter Thiel’s ‘sociopathic’ response about the future of humanity

    People have been creeped out by how he answered a simple question

    News
  • 10 hours ago

    Doctor issues warning over hidden symptoms of Lyme disease as tick bites near record highs in US states

    Parts of the US have seen a sudden uptick in tick bites

    News
  • 11 hours ago

    ‘World’s top couple’s therapist’ reveals the one surprising behavior in people’s relationships that ‘scares her’

    The psychologist said this one thing in other couples doesn't seem real

    News
  • China and USA's rare earth mineral deal could prevent $34,000,000,000 black hole in American economy
  • Man on Ozempic-like drug for over a year reveals shocking impact it had on his body after coming off it
  • Doctors issue warning over 'Ozempic aftermath' as new brutal side effects are revealed
  • Shocking way people are fixing 'Ozempic face' as simulation shows what drug actually does to your body